心血管疾病风险患者冠状动脉钙化评分与心肌灌注显像的联合评估:现状与数据解读
本文综述了在因心肌灌注显像评估而转诊的心血管疾病风险患者中,联合应用冠状动脉钙化评分与心肌灌注显像的现状与数据。文章旨在分析联合影像的当前与潜在特征,以提供增量预后信息,帮助临床医生管理患者并减少不良事件。
要点
- 联合冠状动脉钙化评分与心肌灌注显像可能为心血管疾病风险患者提供增量预后信息。
- 影像学检查有助于早期识别预后不良高风险个体,并提示风险因素修正。
- 本文分析了联合影像在心肌灌注显像转诊患者中的现状与潜在特征。
核心结论
- 联合影像评估可能提供增量预后信息,帮助临床医生管理患者并减少不良事件。
研究设计与样本
- 本文为综述,分析因心肌灌注显像评估转诊的心血管疾病风险患者中联合影像的现状。
主要发现
- 过去数十年心血管疾病预防与治疗的进步使心血管疾病死亡率显著下降。
- 动脉粥样硬化导致冠状动脉疾病和卒中仍是全球最常见死因之一。
- 影像学检查有助于早期识别疾病并识别预后不良高风险个体,提示风险因素修正。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Advances in the prevention and treatment of cardiovascular disease (CVD) over the last decades have led to a marked reduction in mortality for CVD. Nevertheless, atherosclerosis leading to coronary artery disease and stroke remains one of the most common causes of death in the world. The usefulness of imaging tests in the early identification of disease led to identify subjects at major risk of poor outcomes, suggesting risk factor modification. The aim of this article is to analyze the state of art of combined imaging in patients at risk of CVD referred to MPI evaluation, to highlight the present and potential features able to provide incremental prognostic information to help clinicians in patient management and to reduce adverse events.
引用
- Mannarino T, D'Antonio A, Assante R, et al. Combined evaluation of CAC score and myocardial perfusion imaging in patients at risk of cardiovascular disease: where are we and what do the data say. J Nucl Cardiol. 2023. PMID: 37162738. doi:10.1007/s12350-023-03288-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。